Probucol Protects Against Atherosclerosis Through Lipid-lowering and Suppressing Immune Maturation of CD11c+ Dendritic Cells in STZ-induced Diabetic LDLR−/− Mice-Reference-Cited by-同舟云学术

Probucol Protects Against Atherosclerosis Through Lipid-lowering and Suppressing Immune Maturation of CD11c+ Dendritic Cells in STZ-induced Diabetic LDLR−/− Mice

Published:2015-06 Issue:6 Volume:65 Page:620-627
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:Journal of Cardiovascular Pharmacology

Author:

Zhu Hong,Jin Xueting,Zhao Jingjing,Dong Zhen,Ma Xin,Xu Fang,Huang Wei,Liu George,Zou Yunzeng,Wang Keqiang,Hu Kai,Sun Aijun,Ge Junbo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference35 articles.

1. Dendritic cells in atherosclerosis: current status of the problem and clinical relevance

2. Arterial Inflammation and Atherosclerosis

3. Potential role of dendritic cells in atherogenesis

4. Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques

5. Dendritic cells and the control of immunity

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological therapy targeting the immune response in atherosclerosis;International Immunopharmacology;2024-11

2. Research and Progress of Probucol in Nonalcoholic Fatty Liver Disease;Mini-Reviews in Medicinal Chemistry;2023-10

3. XCR1+ conventional dendritic cell-induced CD4+ T helper 1 cell activation exacerbates cardiac remodeling after ischemic myocardial injury;Journal of Molecular and Cellular Cardiology;2023-03

4. Density functional studies of probucol excited states and spectral properties;The European Physical Journal D;2023-01

5. Atorvastatin-induced tolerogenic dendritic cells improve cardiac remodeling by suppressing TLR-4/NF-κB activation after myocardial infarction;Inflammation Research;2022-10-31